Skip to content

Should your company access the U.S. capital markets?

Multijurisdictional Disclosure System

U.S. market access for Canadian issuers

A written view before you spend on filings: the route that fits, who would actually buy the stock in the U.S., what it costs, how long it takes, and whether proceeding is worth it at all. MJDS is one route. It is not the only one.

PathsF-1040-FF-7F-8F-8014d-1

The diagnostic takes four minutes, needs no account, and nothing leaves your browser unless you choose to send it. Every result is indicative and every threshold carries its source.

Minimum non-affiliate public float
US$75MMinimum non-affiliate public float
Continuous Canadian reporting required
12–36 monthsContinuous Canadian reporting required
F-10 · F-7 · F-8 · F-80 · 40-F · 6-K
6 formsF-10 · F-7 · F-8 · F-80 · 40-F · 6-K
Annual foreign private issuer retest
1 dateAnnual foreign private issuer retest

SEC Form F-10, General Instruction I.C (current public float) · verified Nov 19, 2026 · SEC Form F-10, General Instruction I.C; Form 40-F · verified Nov 19, 2026 · exchange standards · verified Nov 19, 2026

The engagement

The advice comes before the filing.

The work starts with how your stock trades, who might buy it in the U.S., and whether the economics justify the work — not with a form. Most firms here sell the filing. We are hired to tell you whether the filing is worth buying.

Then, if the answer is yes, the same desk runs the process alongside your counsel, auditor and banker.

The six stages
  1. 01

    The route

    Which registration or listing fits your facts: MJDS, a Form F-1 offering, a Form 20-F listing of shares you already have, a private placement — or none of them yet.

  2. 02

    The demand

    How your shares actually trade — price, float, volume, holder mix — and who in the U.S. would be a realistic buyer, mandate by mandate.

  3. 03

    The cost

    Filing, audit, legal and ongoing reporting costs in dollars, and the months each one consumes before anything reaches a market.

  4. 04

    The judgment

    A written recommendation: proceed, fix these three things first, or do not spend the money. In writing, so your board can act on it.

About MJDS Advisory

U.S. capital markets advisory for Canadian issuers

MJDS Advisory helps Canadian public companies decide whether a U.S. listing, registered offering, or OTC quotation makes sense for their business. We look at how your stock trades today, who could realistically own it in the U.S., and what the transaction would cost to execute and maintain. Management and the board get a written recommendation they can use to make a decision.

If you decide to proceed, we run point with management. We help select the route, build the transaction calendar, and coordinate Canadian and U.S. securities counsel, auditors, filing agents, and banking partners through execution.

A representative example

When a Nasdaq listing should wait

A TSXV issuer trading at C$0.85 with C$6 million in public float approached us about a Nasdaq listing. We recommended holding off on the application. A share consolidation or ADR ratio could address the quoted price, but the company would still need more unrestricted public float. We recommended tracking float and qualifying round-lot holders quarterly and reassessing in 12 months.

In parallel, we began exploring whether a U.S. public offering registered on Form F-1 could bring the listing forward. A sufficiently sized offering could build the required float. The first step was to assess whether a U.S. investment bank could underwrite the deal at a size and price that served the company's capital needs and kept dilution acceptable.

An anonymised example. Outcomes depend on each issuer's own facts.

Leadership

Ari Gross

Founder · MJDS Advisory

Ari Gross is a Toronto-based capital markets adviser with a background in special-situations investing and small-cap shareholder activism. He worked as an analyst at an activist fund, where he facilitated reverse takeovers, capital raises and other strategic transactions, before founding Capital AnG and Ventures of Space.

His current advisory work includes a Canadian biotech company pursuing a Nasdaq uplisting, a medtech IPO, and a robotics spinout targeting a U.S. listing. He also advises companies on bridge financing, convertible debt, and growth capital. He brings relationships with family offices, hedge funds, and investment banks across Canada and the U.S.

Contact the desk

Canadian and U.S. securities counsel

We work with securities counsel in Canada and the United States who focus on capital markets. Counsel handles legal eligibility, transaction documentation, and regulatory filings. MJDS Advisory leads the commercial assessment and coordinates the work across both sides of the border. We can work alongside the advisers you already have in place.

Not a fit for MJDS?
There are other doors.

OTCQX, a private placement, a business-combination structure, or a direct U.S. listing where the standards are met. Tell us about your stock and we will tell you which of them is realistic — and what it would take.